Urinary incontinence (UI) is a common and often distressing condition that significantly impacts a patient’s quality of life. Effective management, a key topic in the “Urological Disorders” module of the Patient Care 5 curriculum, depends on correctly identifying the type of incontinence—be it stress, urge, or overflow. This quiz will test your knowledge of the pathophysiology, non-pharmacologic interventions, and the pharmacotherapy of urinary incontinence, with a focus on anticholinergic agents and beta-3 agonists used to treat overactive bladder.
1. A patient reports leaking urine when they cough, sneeze, or laugh. This is characteristic of which type of urinary incontinence?
- a. Urge incontinence
- b. Stress incontinence
- c. Overflow incontinence
- d. Functional incontinence
Answer: b. Stress incontinence
2. Urge incontinence, the primary symptom of Overactive Bladder (OAB), is caused by:
- a. An underactive detrusor muscle.
- b. A blockage at the bladder outlet.
- c. Involuntary contractions of the detrusor muscle.
- d. A weak urethral sphincter.
Answer: c. Involuntary contractions of the detrusor muscle.
3. Which class of medications is considered first-line pharmacotherapy for Urge UI / Overactive Bladder?
- a. Alpha-blockers
- b. Beta-3 adrenergic agonists
- c. Anticholinergic/antimuscarinic agents
- d. Loop diuretics
Answer: c. Anticholinergic/antimuscarinic agents
4. What is the primary mechanism of action for anticholinergic agents like oxybutynin in treating OAB?
- a. They stimulate beta-3 receptors to relax the bladder.
- b. They block M3 muscarinic receptors on the detrusor muscle, causing it to relax.
- c. They increase the tone of the urethral sphincter.
- d. They block dopamine receptors.
Answer: b. They block M3 muscarinic receptors on the detrusor muscle, causing it to relax.
5. A patient taking immediate-release oxybutynin is most likely to complain of which side effect?
- a. Diarrhea
- b. Increased salivation
- c. Dry mouth
- d. Weight loss
Answer: c. Dry mouth
6. The “Management of Urinary Incontinence” is a specific lecture in which course?
- a. PHA5787C Patient Care 5
- b. PHA5104 Sterile Compounding
- c. PHA5703 Pharmacy Law and Ethics
- d. PHA5878C Patient Care 3
Answer: a. PHA5787C Patient Care 5
7. Mirabegron is an alternative to anticholinergics for OAB. What is its mechanism of action?
- a. It is an M3 receptor antagonist.
- b. It is a beta-3 adrenergic agonist that relaxes the detrusor muscle.
- c. It is an alpha-1 antagonist.
- d. It is a 5-alpha reductase inhibitor.
Answer: b. It is a beta-3 adrenergic agonist that relaxes the detrusor muscle.
8. What is the most important first-line, non-pharmacologic intervention for both stress and urge incontinence?
- a. A low-fluid diet.
- b. Pelvic floor muscle exercises (Kegel exercises).
- c. Timed voiding every 30 minutes.
- d. Use of absorbent pads.
Answer: b. Pelvic floor muscle exercises (Kegel exercises).
9. A patient with benign prostatic hyperplasia (BPH) who experiences dribbling and a weak stream is likely to have which type of incontinence?
- a. Stress incontinence
- b. Urge incontinence
- c. Overflow incontinence
- d. Functional incontinence
Answer: c. Overflow incontinence
10. Why are extended-release (ER/XL) formulations of anticholinergics often preferred over immediate-release formulations?
- a. They are more effective.
- b. They have a more favorable side effect profile, particularly less dry mouth.
- c. They are cheaper.
- d. They have a faster onset of action.
Answer: b. They have a more favorable side effect profile, particularly less dry mouth.
11. The management of BPH and urinary incontinence are topics within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
12. A patient using an oxybutynin transdermal patch should be counseled that the patch:
- a. Is less likely to cause dry mouth compared to the oral formulation.
- b. Should be applied to the same site every time.
- c. Should be changed every day.
- d. Can be cut in half.
Answer: a. Is less likely to cause dry mouth compared to the oral formulation.
13. A patient with narrow-angle glaucoma should not be prescribed which medication for OAB?
- a. Mirabegron
- b. An anticholinergic agent like tolterodine
- c. Tamsulosin
- d. All of these are safe.
Answer: b. An anticholinergic agent like tolterodine
14. The primary treatment for overflow incontinence caused by BPH is:
- a. An anticholinergic medication.
- b. Treatment of the underlying BPH with an alpha-blocker or 5-alpha reductase inhibitor.
- c. Pelvic floor muscle exercises.
- d. A bladder training regimen.
Answer: b. Treatment of the underlying BPH with an alpha-blocker or 5-alpha reductase inhibitor.
15. A pharmacist counseling a patient on UI should first:
- a. Recommend the newest medication available.
- b. Try to determine the type of incontinence the patient is experiencing.
- c. Recommend adult diapers.
- d. Tell the patient the condition is untreatable.
Answer: b. Try to determine the type of incontinence the patient is experiencing.
16. “Introduction to Urological Disorders” is a lecture within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
17. Mirabegron should be used with caution in which patient population?
- a. Patients with hypotension.
- b. Patients with severe, uncontrolled hypertension.
- c. Patients with diabetes.
- d. Patients with asthma.
Answer: b. Patients with severe, uncontrolled hypertension.
18. Which of the following is a behavioral therapy technique for OAB?
- a. Bladder training (scheduled voiding with increasing intervals).
- b. Urge suppression techniques.
- c. Fluid management.
- d. All of the above.
Answer: d. All of the above.
19. Which of the following drugs can exacerbate stress incontinence by causing relaxation of the urethral sphincter?
- a. Pseudoephedrine
- b. An alpha-blocker like prazosin
- c. An anticholinergic
- d. A beta-3 agonist
Answer: b. An alpha-blocker like prazosin
20. An active learning session on urological disorders is part of the Patient Care 5 course.
- a. True
- b. False
Answer: a. True
21. A patient with cognitive impairment who repeatedly falls on the way to the bathroom is experiencing what type of incontinence?
- a. Stress
- b. Urge
- c. Overflow
- d. Functional
Answer: d. Functional
22. Which anticholinergic agent is more selective for M3 receptors, potentially leading to fewer CNS side effects?
- a. Oxybutynin IR
- b. Tolterodine
- c. Solifenacin and Darifenacin
- d. Trospium
Answer: c. Solifenacin and Darifenacin
23. The pharmacist’s role in managing UI includes:
- a. Recommending appropriate non-pharmacologic interventions.
- b. Counseling on the side effects of medications.
- c. Assessing for potential drug interactions.
- d. All of the above.
Answer: d. All of the above.
24. An active learning session on urological disorders is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
25. A patient complains of leaking urine with a sudden, intense need to void. This is the classic symptom of:
- a. Stress UI
- b. Urge UI
- c. Overflow UI
- d. Functional UI
Answer: b. Urge UI
26. Which medication for OAB is a beta-3 agonist?
- a. Oxybutynin
- b. Solifenacin
- c. Tolterodine
- d. Mirabegron
Answer: d. Mirabegron
27. The detrusor muscle of the bladder is primarily under the control of which part of the nervous system for contraction?
- a. Sympathetic (adrenergic)
- b. Parasympathetic (cholinergic)
- c. Somatic
- d. Central
Answer: b. Parasympathetic (cholinergic)
28. An active learning session on urological disorders is part of which course module?
- a. Module 8: Urological Disorders
- b. Module 1: Diabetes Mellitus
- c. Module 3: Women’s Health
- d. Module 6: Geriatrics
Answer: a. Module 8: Urological Disorders
29. The main advantage of mirabegron over anticholinergic agents is:
- a. It is more effective.
- b. It is cheaper.
- c. It lacks anticholinergic side effects like dry mouth and constipation.
- d. It is dosed once a week.
Answer: c. It lacks anticholinergic side effects like dry mouth and constipation.
30. The management of BPH and UI is a lecture within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
31. Which of the following is a common cause of overflow incontinence?
- a. A weak detrusor muscle.
- b. A bladder outlet obstruction (e.g., BPH).
- c. Both a and b.
- d. Neither a nor b.
Answer: c. Both a and b.
32. A patient with dementia is prescribed oxybutynin IR for urge incontinence. The pharmacist should be concerned about:
- a. Worsening cognitive function.
- b. The risk of hypertension.
- c. The risk of diarrhea.
- d. The patient developing a cough.
Answer: a. Worsening cognitive function.
33. What is the role of a bladder diary in the management of UI?
- a. To track medication costs.
- b. To help characterize the type and severity of incontinence by tracking fluid intake, voiding times, and leakage episodes.
- c. It has no role in management.
- d. To monitor for side effects only.
Answer: b. To help characterize the type and severity of incontinence by tracking fluid intake, voiding times, and leakage episodes.
34. The primary treatment for functional incontinence is:
- a. An anticholinergic drug.
- b. Mirabegron.
- c. Addressing the underlying functional limitation (e.g., scheduled toileting, bedside commode).
- d. A diuretic.
Answer: c. Addressing the underlying functional limitation (e.g., scheduled toileting, bedside commode).
35. An onabotulinumtoxinA (Botox) injection into the detrusor muscle is a third-line treatment option for:
- a. Refractory urge incontinence / OAB.
- b. Stress incontinence.
- c. Overflow incontinence.
- d. Functional incontinence.
Answer: a. Refractory urge incontinence / OAB.
36. A patient reports that their urine leaks constantly without any sensation of needing to void. This is most suggestive of:
- a. Stress UI
- b. Urge UI
- c. Overflow UI
- d. Mixed UI
Answer: c. Overflow UI
37. Which of the following medications can worsen UI by causing sedation and delirium, especially in the elderly?
- a. Benzodiazepines
- b. Opioids
- c. First-generation antihistamines
- d. All of the above
Answer: d. All of the above
38. The lecture “Management of BPH and Urinary Incontinence” is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
39. Before starting pharmacotherapy for OAB, a trial of what is recommended?
- a. A high-fluid diet.
- b. Behavioral therapy for at least 4-6 weeks.
- c. A stimulant laxative.
- d. An antidepressant.
Answer: b. Behavioral therapy for at least 4-6 weeks.
40. An active learning session covering urological disorders is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
41. The anticholinergic burden is a significant concern when treating UI in which patient population?
- a. Pediatric patients
- b. Young adults
- c. Geriatric patients
- d. Pregnant patients
Answer: c. Geriatric patients
42. Which of the following is a non-pharmacologic strategy for managing UI?
- a. Limiting caffeine and alcohol intake.
- b. Timed voiding.
- c. Weight loss in overweight patients.
- d. All of the above.
Answer: d. All of the above.
43. A pharmacist’s role in the management of UI is limited to dispensing medications.
- a. True
- b. False
Answer: b. False
44. Which alpha-agonist is sometimes used off-label to treat stress incontinence by increasing urethral sphincter tone?
- a. Clonidine
- b. Prazosin
- c. Pseudoephedrine
- d. Tamsulosin
Answer: c. Pseudoephedrine
45. The pathophysiology of stress incontinence involves weakness of the:
- a. Detrusor muscle
- b. Abdominal muscles
- c. Pelvic floor muscles and urethral sphincter
- d. Ureters
Answer: c. Pelvic floor muscles and urethral sphincter
46. A patient has both symptoms of stress and urge incontinence. This is known as:
- a. Overflow incontinence
- b. Functional incontinence
- c. Mixed incontinence
- d. Total incontinence
Answer: c. Mixed incontinence
47. Counseling on the management of UI is part of the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
48. An active learning session on urological disorders is part of which course module?
- a. Module 8: Urological Disorders
- b. Module 1: Diabetes Mellitus
- c. Module 4: Medication Safety
- d. Module 6: Geriatrics
Answer: a. Module 8: Urological Disorders
49. The overall management of urinary incontinence should be:
- a. A “one-size-fits-all” approach.
- b. Focused only on pharmacotherapy.
- c. Individualized based on the type of UI and patient-specific factors.
- d. Handled only by a urologist.
Answer: c. Individualized based on the type of UI and patient-specific factors.
50. The ultimate goal of learning about the management of urinary incontinence is to:
- a. Help patients improve their quality of life by providing safe and effective treatment strategies.
- b. Memorize all the brand names of anticholinergic drugs.
- c. Pass the final exam.
- d. Convince all patients to have surgery.
Answer: a. Help patients improve their quality of life by providing safe and effective treatment strategies.
